Literature DB >> 33169436

Multiomic analysis elucidates Complex I deficiency caused by a deep intronic variant in NDUFB10.

Guy Helman1,2, Alison G Compton1,3, Daniella H Hock4, Marzena Walkiewicz1, Gemma R Brett3,5, Lynn Pais6, Tiong Y Tan1,3,5, Ricardo De Paoli-Iseppi7, Michael B Clark7, John Christodoulou1,3,5, Susan M White3,5, David R Thorburn1,3,5, David A Stroud4, Zornitza Stark3,5, Cas Simons1,2.   

Abstract

The diagnosis of Mendelian disorders following uninformative exome and genome sequencing remains a challenging and often unmet need. Following uninformative exome and genome sequencing of a family quartet including two siblings with suspected mitochondrial disorder, RNA sequencing (RNAseq) was pursued in one sibling. Long-read amplicon sequencing was used to determine and quantify transcript structure. Immunoblotting studies and quantitative proteomics were performed to demonstrate functional impact. Differential expression analysis of RNAseq data identified significantly decreased expression of the mitochondrial OXPHOS Complex I subunit NDUFB10 associated with a cryptic exon in intron 1 of NDUFB10, that included an in-frame stop codon. The cryptic exon contained a rare intronic variant that was homozygous in both affected siblings. Immunoblot and quantitative proteomic analysis of fibroblasts revealed decreased abundance of Complex I subunits, providing evidence of isolated Complex I deficiency. Through multiomic analysis we present data implicating a deep intronic variant in NDUFB10 as the cause of mitochondrial disease in two individuals, providing further support of the gene-disease association. This study highlights the importance of transcriptomic and proteomic analyses as complementary diagnostic tools in patients undergoing genome-wide diagnostic evaluation.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  RNA sequencing; aberrant splicing; genomics; mitochondrial disease; proteomics

Mesh:

Substances:

Year:  2020        PMID: 33169436      PMCID: PMC7902361          DOI: 10.1002/humu.24135

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  16 in total

1.  Improving genetic diagnosis in Mendelian disease with transcriptome sequencing.

Authors:  Beryl B Cummings; Jamie L Marshall; Taru Tukiainen; Monkol Lek; Sandra Donkervoort; A Reghan Foley; Veronique Bolduc; Leigh B Waddell; Sarah A Sandaradura; Gina L O'Grady; Elicia Estrella; Hemakumar M Reddy; Fengmei Zhao; Ben Weisburd; Konrad J Karczewski; Anne H O'Donnell-Luria; Daniel Birnbaum; Anna Sarkozy; Ying Hu; Hernan Gonorazky; Kristl Claeys; Himanshu Joshi; Adam Bournazos; Emily C Oates; Roula Ghaoui; Mark R Davis; Nigel G Laing; Ana Topf; Peter B Kang; Alan H Beggs; Kathryn N North; Volker Straub; James J Dowling; Francesco Muntoni; Nigel F Clarke; Sandra T Cooper; Carsten G Bönnemann; Daniel G MacArthur
Journal:  Sci Transl Med       Date:  2017-04-19       Impact factor: 17.956

2.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

Review 3.  Mitochondrial energy generation disorders: genes, mechanisms, and clues to pathology.

Authors:  Ann E Frazier; David R Thorburn; Alison G Compton
Journal:  J Biol Chem       Date:  2017-12-12       Impact factor: 5.157

4.  Accessory subunits are integral for assembly and function of human mitochondrial complex I.

Authors:  David A Stroud; Elliot E Surgenor; Luke E Formosa; Boris Reljic; Ann E Frazier; Marris G Dibley; Laura D Osellame; Tegan Stait; Traude H Beilharz; David R Thorburn; Agus Salim; Michael T Ryan
Journal:  Nature       Date:  2016-09-14       Impact factor: 49.962

5.  Predicting Splicing from Primary Sequence with Deep Learning.

Authors:  Kishore Jaganathan; Sofia Kyriazopoulou Panagiotopoulou; Jeremy F McRae; Siavash Fazel Darbandi; David Knowles; Yang I Li; Jack A Kosmicki; Juan Arbelaez; Wenwu Cui; Grace B Schwartz; Eric D Chow; Efstathios Kanterakis; Hong Gao; Amirali Kia; Serafim Batzoglou; Stephan J Sanders; Kyle Kai-How Farh
Journal:  Cell       Date:  2019-01-17       Impact factor: 41.582

6.  Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts.

Authors:  Laure Frésard; Craig Smail; Nicole M Ferraro; Nicole A Teran; Xin Li; Kevin S Smith; Devon Bonner; Kristin D Kernohan; Shruti Marwaha; Zachary Zappala; Brunilda Balliu; Joe R Davis; Boxiang Liu; Cameron J Prybol; Jennefer N Kohler; Diane B Zastrow; Chloe M Reuter; Dianna G Fisk; Megan E Grove; Jean M Davidson; Taila Hartley; Ruchi Joshi; Benjamin J Strober; Sowmithri Utiramerur; Lars Lind; Erik Ingelsson; Alexis Battle; Gill Bejerano; Jonathan A Bernstein; Euan A Ashley; Kym M Boycott; Jason D Merker; Matthew T Wheeler; Stephen B Montgomery
Journal:  Nat Med       Date:  2019-06-03       Impact factor: 53.440

Review 7.  Mitochondrial diseases.

Authors:  Gráinne S Gorman; Patrick F Chinnery; Salvatore DiMauro; Michio Hirano; Yasutoshi Koga; Robert McFarland; Anu Suomalainen; David R Thorburn; Massimo Zeviani; Douglass M Turnbull
Journal:  Nat Rev Dis Primers       Date:  2016-10-20       Impact factor: 52.329

8.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

9.  Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease.

Authors:  Hernan D Gonorazky; Sergey Naumenko; Arun K Ramani; Viswateja Nelakuditi; Pouria Mashouri; Peiqui Wang; Dennis Kao; Krish Ohri; Senthuri Viththiyapaskaran; Mark A Tarnopolsky; Katherine D Mathews; Steven A Moore; Andres N Osorio; David Villanova; Dwi U Kemaladewi; Ronald D Cohn; Michael Brudno; James J Dowling
Journal:  Am J Hum Genet       Date:  2019-02-28       Impact factor: 11.025

10.  Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns.

Authors:  Alison D Tang; Cameron M Soulette; Marijke J van Baren; Kevyn Hart; Eva Hrabeta-Robinson; Catherine J Wu; Angela N Brooks
Journal:  Nat Commun       Date:  2020-03-18       Impact factor: 17.694

View more
  5 in total

1.  Lessons learnt from multifaceted diagnostic approaches to the first 150 families in Victoria's Undiagnosed Diseases Program.

Authors:  Thomas Cloney; Lyndon Gallacher; Lynn S Pais; Natalie B Tan; Alison Yeung; Zornitza Stark; Natasha J Brown; George McGillivray; Martin B Delatycki; Michelle G de Silva; Lilian Downie; Chloe A Stutterd; Justine Elliott; Alison G Compton; Alysia Lovgren; Ralph Oertel; David Francis; Katrina M Bell; Simon Sadedin; Sze Chern Lim; Guy Helman; Cas Simons; Daniel G Macarthur; David R Thorburn; Anne H O'Donnell-Luria; John Christodoulou; Susan M White; Tiong Yang Tan
Journal:  J Med Genet       Date:  2021-11-05       Impact factor: 5.941

2.  A Novel Mitochondrial-Related Gene Signature for the Tumor Immune Microenvironment Evaluation and Prognosis Prediction in Lung Adenocarcinoma.

Authors:  Yin-Ping Li; Gui-Xia Liu; Zhan-Ling Wu; Ping-Hua Tu; Guang Wei; Man Yuan; Min-Hua Zhong; Ke-Lan Deng
Journal:  J Immunol Res       Date:  2022-05-25       Impact factor: 4.493

3.  Application of Genome Sequencing from Blood to Diagnose Mitochondrial Diseases.

Authors:  Rocio Rius; Alison G Compton; Naomi L Baker; AnneMarie E Welch; David Coman; Maina P Kava; Andre E Minoche; Mark J Cowley; David R Thorburn; John Christodoulou
Journal:  Genes (Basel)       Date:  2021-04-20       Impact factor: 4.096

4.  Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.

Authors:  Niall P Keegan; Steve D Wilton; Sue Fletcher
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.772

Review 5.  The genetics of mitochondrial disease: dissecting mitochondrial pathology using multi-omic pipelines.

Authors:  Charlotte L Alston; Sarah L Stenton; Gavin Hudson; Holger Prokisch; Robert W Taylor
Journal:  J Pathol       Date:  2021-03-26       Impact factor: 9.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.